Traditional Chinese Medicine for the Treatment of COVID 19 (Omicron): A Registry Study
- Conditions
- Covid 19 (Omicron)
- Registration Number
- ITMCTR2200005800
- Lead Sponsor
- The Affiliated Hospital of Changchun University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Patients who meet the diagnostic criteria for mild and moderate types of COVID-19 in the Diagnosis and Treatment Program for Novel Coronavirus Pneumonia (Trial Ninth Version);
2. Local cases and related cases in Jilin Province that appeared after March 1, 2022;
3. Patients are managed by the medical team of the Affiliated Hospital of Changchun University of Chinese Medicine;
4. Sign the informed consent.
1. Patients without medical information;
2. Suspected and imported cases;
3. Pregnant women, pregnant or lactating women;
4. Patients with previous allergy to traditional Chinese medicine.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method